Profile data is unavailable for this security.
About the company
Integrated BioPharma, Inc. is engaged in the business of manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company’s business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers and Other Nutraceutical Businesses, which includes the operations of AgroLabs, Inc. (AgroLabs), The Vitamin Factory (the Vitamin Factory), IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. AgroLabs distributes healthful nutritional products for sale through mass market, grocery and drug and vitamin retailers under the brands: Peaceful Sleep, and Wheatgrass and other products. IHT is a distributor of natural botanicals, including multi-minerals produced under a license agreement. Chem is a distributor of raw materials.
- Revenue in USD (TTM)50.32m
- Net income in USD112.00k
- Incorporated1995
- Employees147.00
- LocationIntegrated Biopharma Inc225 Long Ave Ste 15HILLSIDE 07205-2356United StatesUSA
- Phone+1 (973) 926-0816
- Fax+1 (973) 926-1735
- Websitehttps://ir.ibiopharma.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bon Natural Life Ltd | 25.56m | 2.47m | 5.84m | 96.00 | 0.5608 | 0.0566 | 1.55 | 0.2284 | 2.62 | 2.62 | 22.95 | 25.95 | 0.5254 | 11.40 | 2.94 | 266,207.70 | 4.95 | 14.04 | 6.59 | 20.68 | 27.75 | 30.00 | 9.42 | 17.62 | 2.32 | 16.88 | 0.1438 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
| Silo Pharma Inc | 72.12k | -3.45m | 5.92m | 3.00 | -- | 0.8244 | -- | 82.08 | -1.16 | -1.18 | 0.0242 | 1.60 | 0.0079 | -- | -- | 24,040.00 | -37.69 | -24.90 | -43.50 | -26.39 | 91.90 | 82.79 | -4,777.02 | -2,757.85 | -- | -- | 0.00 | -- | 0.00 | -- | 7.07 | -- | -- | -- |
| Hoth Therapeutics Inc | 0.00 | -7.46m | 6.14m | 2.00 | -- | 0.5106 | -- | -- | -1.69 | -1.69 | 0.00 | 1.74 | 0.00 | -- | -- | 0.00 | -67.99 | -157.07 | -76.33 | -177.32 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 31.01 | -- | -- | -- |
| GT Biopharma Inc | 0.00 | -11.35m | 7.75m | 2.00 | -- | 1.41 | -- | -- | -7.72 | -7.72 | 0.00 | 2.47 | 0.00 | -- | -- | 0.00 | -82.84 | -205.36 | -120.73 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 63.62 | -- | -- | -- |
| Evoke Pharma Inc | 7.53m | -6.53m | 7.99m | 4.00 | -- | 1.48 | -- | 1.06 | -16.23 | -16.23 | 11.24 | 3.63 | 0.7128 | 0.4307 | 4.97 | 1,881,428.00 | -61.83 | -100.48 | -136.53 | -151.10 | 96.97 | -- | -86.75 | -480.52 | 1.22 | -19.91 | 0.6523 | -- | 106.51 | -- | 5.25 | -- | -- | -- |
| CV Sciences Inc | 15.85m | -2.53m | 8.13m | 42.00 | -- | 3.24 | -- | 0.513 | -0.0157 | -0.0157 | 0.098 | 0.0139 | 1.69 | 1.55 | 25.35 | 377,285.70 | -26.94 | -43.42 | -73.44 | -77.75 | 46.06 | 51.81 | -15.95 | -45.68 | 0.2530 | -- | 0.0114 | -- | -1.24 | -19.80 | 133.96 | -20.87 | -- | -- |
| Coeptis Therapeutics Holdings Inc | 0.00 | -16.14m | 8.26m | 5.00 | -- | -- | -- | -- | -0.5143 | -0.5143 | 0.00 | -0.0111 | 0.00 | -- | -- | 0.00 | -284.35 | -37.29 | -709.12 | -38.23 | -- | -- | -- | -- | -- | -- | 1.22 | -- | -- | -- | 43.40 | -- | -- | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 9.30m | 233.00 | 0.0624 | 0.001 | 2.41 | 0.1313 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| Integrated BioPharma, Inc. | 50.32m | 112.00k | 9.92m | 147.00 | 124.89 | 0.5159 | 22.40 | 0.1972 | 0.0026 | 0.0026 | 1.62 | 0.6391 | 1.95 | 4.32 | 10.96 | 342,292.50 | 0.4338 | 13.15 | 0.5505 | 19.97 | 7.72 | 11.22 | 0.2226 | 5.87 | 1.08 | -- | 0.0004 | -- | -0.7006 | 0.1357 | 806.25 | -41.77 | 5.96 | -- |
| Aytu Biopharma Inc | 81.00m | -15.84m | 10.88m | 99.00 | -- | 0.3814 | -- | 0.1344 | -2.86 | -2.86 | 14.63 | 4.64 | 0.6364 | 2.15 | 3.08 | 818,202.00 | -12.45 | -27.76 | -25.70 | -46.03 | 67.39 | 58.88 | -19.56 | -56.45 | 0.7916 | -0.0594 | 0.3531 | -- | -24.58 | 61.73 | 7.08 | -- | -- | -- |
| Bio Essence Corp | 593.21k | -1.02m | 11.59m | 12.00 | -- | -- | -- | 19.53 | -0.0278 | -0.0156 | 0.0158 | -0.0458 | 0.3305 | -- | 21.20 | -- | -57.09 | -46.10 | -- | -- | 25.05 | 33.89 | -172.74 | -111.21 | -- | -59.99 | 7.03 | -- | -11.27 | -10.94 | -52.03 | -- | -48.19 | -- |
| NDT Pharmaceuticals Inc | -100.00bn | -100.00bn | 12.59m | 1.00 | -- | 0.0703 | -- | -- | -- | -- | -- | 1.12 | -- | -- | -- | -- | -- | -164.47 | -- | -452.47 | -- | -- | -- | -6,891.36 | -- | -- | 0.00 | -- | -100.00 | -- | 87.56 | -- | -- | -- |
| Immunoprecise Antibodies Ltd | 17.30m | -19.83m | 12.91m | 102.00 | -- | 0.518 | -- | 0.746 | -0.7492 | -0.7492 | 0.6615 | 0.8642 | 0.3546 | 6.12 | 6.16 | -- | -40.63 | -26.70 | -46.68 | -30.31 | 48.21 | 56.13 | -114.58 | -85.72 | 0.8189 | -134.72 | 0.3289 | -- | 18.65 | 17.54 | -2.32 | -- | 16.71 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Moloney Securities Asset Management LLCas of 30 Sep 2024 | 20.00k | 0.07% |
